{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T07:12:02Z","timestamp":1778483522157,"version":"3.51.4"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.critrevonc.2026.105287","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:48:20Z","timestamp":1773938900000},"page":"105287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cumulative lung dose\u2013volume predictors of radiation pneumonitis in thoracic reirradiation: A systematic scoping review"],"prefix":"10.1016","volume":"222","author":[{"given":"Thomas","family":"Fr\u00e9d\u00e9ric-Moreau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolaus","family":"Andratschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Antoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Chua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges","family":"Noel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Loo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Willmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ane","family":"Appelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5512-4161","authenticated-orcid":false,"given":"Arnaud","family":"Beddok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105287_bib1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1748-717X-9-210","article-title":"Stereotactic body radiation therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review","volume":"9","author":"Amini","year":"2014","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib2","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S1470-2045(22)00447-8","article-title":"European society for radiotherapy and oncology and European organisation for research and treatment of cancer consensus on re-irradiation: definition, reporting, and clinical decision making","volume":"23","author":"Andratschke","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib3","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non\u2013small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2026.105287_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6963-4-38","article-title":"Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group","volume":"4","author":"Atkins","year":"2004","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.critrevonc.2026.105287_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fonc.2017.00083","article-title":"Data-based radiation oncology: design of clinical trials in the toxicity biomarkers era","volume":"7","author":"Azria","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib6","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.prro.2019.02.008","article-title":"Clinical outcomes of patients with recurrent lung cancer reirradiated with proton therapy on the proton collaborative group and university of florida proton therapy institute prospective registry studies","volume":"9","author":"Badiyan","year":"2019","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1470-2045(18)30896-9","article-title":"Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial","volume":"20","author":"Ball","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib8","article-title":"Reirradiation: standards, challenges, and patient-focused strategies across tumor types","author":"Beddok","year":"2025","journal-title":"Ca. Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2026.105287_bib9","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non\u2013small-cell lung cancer: nrg oncology\/RTOG 0813 trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib10","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ijrobp.2015.12.007","article-title":"Dosimetric factors and toxicity in highly conformal thoracic reirradiation","volume":"94","author":"Binkley","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2026.105287_bib11","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1200\/JCO.2007.12.6581","article-title":"Definitive chemoradiation for the treatment of locally advanced non\u2013small-cell lung cancer","volume":"25","author":"Blackstock","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib12","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.3390\/cancers15245869","article-title":"Combination of local ablative techniques with radiotherapy for primary and recurrent lung cancer: a systematic review","volume":"15","author":"Bonome","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105287_bib13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.clon.2019.02.006","article-title":"Radiogenomics in the era of advanced radiotherapy","volume":"31","author":"Brothwell","year":"2019","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib14","first-page":"281","article-title":"Multi-institutional prospective study of reirradiation with proton beam radiotherapy for locoregionally recurrent non-small cell lung cancer","volume":"12","author":"Chao","year":"2017","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"},{"key":"10.1016\/j.critrevonc.2026.105287_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2017.01.244","article-title":"Tolerance of the Brachial Plexus to High-Dose Reirradiation","volume":"98","author":"Chen","year":"2017","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib16","doi-asserted-by":"crossref","unstructured":"Cumpston, M.S., McKenzie, J.E., Welch, V.A., Brennan, S.E., 2022. Strengthening systematic reviews in public health: guidance in the Cochrane Handbook for Systematic Reviews of Interventions, 2nd edition. J. Public Health Oxf. Engl. 44, e588\u2013e592. https:\/\/doi.org\/10.1093\/pubmed\/fdac036.","DOI":"10.1093\/pubmed\/fdac036"},{"key":"10.1016\/j.critrevonc.2026.105287_bib17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ctrv.2015.04.002","article-title":"Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies","volume":"41","author":"De Bari","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.critrevonc.2026.105287_bib18","doi-asserted-by":"crossref","first-page":"e620","DOI":"10.1016\/S1470-2045(14)70345-6","article-title":"High-dose re-irradiation following radical radiotherapy for non-small-cell lung cancer","volume":"15","author":"De Ruysscher","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.radonc.2013.02.002","article-title":"Aortic dose constraints when reirradiating thoracic tumors","volume":"106","author":"Evans","year":"2013","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib20","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.3390\/cancers15205083","article-title":"Ultra-hypofractionated re-irradiation with anti-PD-1 immunotherapy for locoregionally recurrent (after radical chemo-radiotherapy) non-small cell lung cancer","volume":"15","author":"Filippatos","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105287_bib21","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3390\/curroncol28030170","article-title":"Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective Analysis","volume":"28","author":"Grambozov","year":"2021","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/cancers14030573","article-title":"High dose thoracic re-irradiation and chemo-immunotherapy for centrally recurrent NSCLC","volume":"14","author":"Grambozov","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105287_bib23","article-title":"The Association between TGF-\u03b21 polymorphisms and radiation pneumonia in lung cancer patients treated with definitive radiotherapy: a meta-analysis","volume":"9","author":"He","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.critrevonc.2026.105287_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.prro.2017.07.002","article-title":"Reirradiation of thoracic cancers with intensity modulated proton therapy","volume":"8","author":"Ho","year":"2018","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib25","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4143\/crt.2018.472","article-title":"High-dose thoracic re-irradiation of lung cancer using highly conformal radiotherapy is effective with acceptable toxicity","volume":"51","author":"Hong","year":"2019","journal-title":"Cancer Res. Treat. Off. J. Korean Cancer Assoc."},{"key":"10.1016\/j.critrevonc.2026.105287_bib26","doi-asserted-by":"crossref","DOI":"10.21037\/cco.2017.07.01","article-title":"Re-irradiation with stereotactic body radiation therapy (SBRT)","volume":"6","author":"H\u00f8yer","year":"2017","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib27","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.clon.2016.08.005","article-title":"Functional image-guided radiotherapy planning for normal lung avoidance","volume":"28","author":"Ireland","year":"2016","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib28","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1038\/s41598-021-83210-3","article-title":"In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO)","volume":"11","author":"John","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105287_bib29","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ijrobp.2009.09.070","article-title":"Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation","volume":"78","author":"Kelly","year":"2010","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.radonc.2013.11.017","article-title":"Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment","volume":"110","author":"Kilburn","year":"2014","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1118\/1.4937599","article-title":"Estimating lung ventilation directly from 4D CT Hounsfield unit values: estimating lung ventilation from 4DCT HU values","volume":"43","author":"Kipritidis","year":"2015","journal-title":"Med. Phys."},{"key":"10.1016\/j.critrevonc.2026.105287_bib32","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1002\/mp.13150","article-title":"The utility of quantitative CT radiomics features for improved prediction of radiation pneumonitis","volume":"45","author":"Krafft","year":"2018","journal-title":"Med. Phys."},{"key":"10.1016\/j.critrevonc.2026.105287_bib33","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ijrobp.2007.10.053","article-title":"Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non\u2013small-cell lung cancer","volume":"70","author":"Lagerwaard","year":"2008","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib34","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s13014-021-01948-6","article-title":"Treatment outcomes of re-irradiation using stereotactic ablative radiotherapy to lung: a propensity score matching analysis","volume":"16","author":"Lee","year":"2021","journal-title":"Radiat. Oncol. Lond. Engl."},{"key":"10.1016\/j.critrevonc.2026.105287_bib35","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fonc.2019.00269","article-title":"Dosiomics: extracting 3D spatial features from dose distribution to predict incidence of radiation pneumonitis","volume":"9","author":"Liang","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/jrr\/rry067","article-title":"Cytokines and radiation-induced pulmonary injuries","author":"Lierova","year":"2018","journal-title":"J. Radiat. Res. (Tokyo)."},{"key":"10.1016\/j.critrevonc.2026.105287_bib37","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ijrobp.2012.02.020","article-title":"Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy","volume":"84","author":"Liu","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2026.105287_bib38","doi-asserted-by":"crossref","DOI":"10.1177\/1533033818798633","article-title":"A systematic literature review on salvage radiotherapy for local or regional recurrence after previous stereotactic body radiotherapy for lung cancer","volume":"17","author":"Matsuo","year":"2018","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2026.105287_bib39","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.ijrobp.2014.07.030","article-title":"Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes","volume":"90","author":"McAvoy","year":"2014","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib40","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.radonc.2013.03.015","article-title":"Reirradiation and stereotactic radiotherapy for tumors in the lung: Dose summation and toxicity","volume":"107","author":"Meijneke","year":"2013","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib41","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijrobp.2024.04.001","article-title":"Incorporation of functional lung imaging into radiation therapy planning in patients with lung cancer: a systematic review and meta-analysis","volume":"120","author":"Midroni","year":"2024","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.21037\/tlcr.2018.08.15","article-title":"Stereotactic body radiotherapy as salvage treatment for recurrence of non-small cell lung cancer after prior surgery or radiotherapy","volume":"8","author":"Milano","year":"2019","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105287_bib43","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/14737140.2019.1686980","article-title":"Stereotactic body radiotherapy in patients with multiple lung tumors: a focus on lung dosimetric constraints","volume":"19","author":"Milano","year":"2019","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105287_bib44","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cllc.2020.06.006","article-title":"Clinical outcomes and predictors of lung toxicity after multiple courses of lung stereotactic body radiotherapy for early-stage non\u2013small cell lung cancer","volume":"22","author":"Muller","year":"2021","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.critrevonc.2026.105287_bib45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12874-018-0611-x","article-title":"Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach","volume":"18","author":"Munn","year":"2018","journal-title":"BMC Med. Res. Method."},{"key":"10.1016\/j.critrevonc.2026.105287_bib46","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.adro.2019.05.007","article-title":"The special medical physics consult process for reirradiation patients","volume":"4","author":"Paradis","year":"2019","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13014-018-1016-z","article-title":"The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation","volume":"13","author":"Ren","year":"2018","journal-title":"Radiat. Oncol. Lond. Engl."},{"key":"10.1016\/j.critrevonc.2026.105287_bib48","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13014-017-0897-6","article-title":"Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation","volume":"12","author":"Repka","year":"2017","journal-title":"Radiat. Oncol. Lond. Engl."},{"key":"10.1016\/j.critrevonc.2026.105287_bib49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1748-717X-8-99","article-title":"Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT)","volume":"8","author":"Reyngold","year":"2013","journal-title":"Radiat. Oncol. Lond. Engl."},{"key":"10.1016\/j.critrevonc.2026.105287_bib50","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.adro.2020.06.006","article-title":"Repeat thoracic stereotactic body radiation therapy (SBRT) for nonsmall cell lung cancer: long-term outcomes, toxicity, and dosimetric considerations","volume":"5","author":"Ricco","year":"2020","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib51","article-title":"An international expert survey on the indications and practice of radical thoracic reirradiation for non-small cell lung cancer","volume":"6","author":"Rulach","year":"2021","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.clon.2017.11.003","article-title":"Re-irradiation for Locally Recurrent Lung Cancer: Evidence, Risks and Benefits","volume":"30","author":"Rulach","year":"2018","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib53","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00066-019-01457-2","article-title":"Re-irradiation in locally recurrent lung cancer patients","volume":"195","author":"Schlampp","year":"2019","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib54","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3109\/0284186X.2013.868035","article-title":"Pattern of loco-regional failure after definitive radiotherapy for non-small cell lung cancer","volume":"53","author":"Schytte","year":"2014","journal-title":"Acta Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2025.03.056","article-title":"American radium society\u2122 appropriate use criteria systematic review and guidelines on reirradiation for non-small cell lung cancer executive summary","author":"Simone","year":"2025","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib56","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semradonc.2020.02.007","article-title":"Proton reirradiation: expert recommendations for reducing toxicities and offering new chances of cure in patients with challenging recurrence malignancies","volume":"30","author":"Simone","year":"2020","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109560","article-title":"A pattern of early radiation-induced inflammatory cytokine expression is associated with lung toxicity in patients with non-small cell lung cancer","volume":"9","author":"Siva","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.critrevonc.2026.105287_bib58","doi-asserted-by":"crossref","unstructured":"Sumita, K., 2016. Re-irradiation for locoregionally recurrent tumors of the thorax: a single-institution, retrospective study.","DOI":"10.1186\/s13014-016-0673-z"},{"key":"10.1016\/j.critrevonc.2026.105287_bib59","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12885-019-5542-3","article-title":"Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer","volume":"19","author":"Sumodhee","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105287_bib60","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13014-020-01590-8","article-title":"Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer","volume":"15","author":"Taugner","year":"2020","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib61","article-title":"Dose mapping using image registration for reirradiation: a systematic review","author":"Thiong\u2019o","year":"2025","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110935","article-title":"A systematic review and meta-analysis of the utility of quantitative, imaging-based approaches to predict radiation-induced toxicity in lung cancer patients","volume":"208","author":"Tong","year":"2025","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib63","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.critrevonc.2026.105287_bib64","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190879","article-title":"Photons or protons for reirradiation in (non-)small cell lung cancer: results of the multicentric ROCOCO in silico study","volume":"93","author":"Troost","year":"2020","journal-title":"Br. J. Radio."},{"key":"10.1016\/j.critrevonc.2026.105287_bib65","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.ijrobp.2014.01.012","article-title":"Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer","volume":"88","author":"Trovo","year":"2014","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib66","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0360-3016(00)01401-2","article-title":"Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach","volume":"49","author":"Tyldesley","year":"2001","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib67","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0140-6736(24)02319-5","article-title":"Radiotherapy toxicities: mechanisms, management, and future directions","volume":"405","author":"Verginadis","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2026.105287_bib68","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.21873\/anticanres.15748","article-title":"Repeated stereotactic body radiotherapy for lung malignancies: toxicity can be reduced by sparing lung irradiation","volume":"42","author":"Watanabe","year":"2022","journal-title":"Anticancer Res"},{"key":"10.1016\/j.critrevonc.2026.105287_bib69","unstructured":"Wells, G, Shea, B, O\u2019Connell, D, et al. (2011) The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses.http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"10.1016\/j.critrevonc.2026.105287_bib70","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3390\/life12020292","article-title":"Toxicity of proton therapy versus photon therapy on salvage re-irradiation for non-small cell lung cancer","volume":"12","author":"Yang","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.critrevonc.2026.105287_bib71","first-page":"76","article-title":"Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer","volume":"22","author":"Yang","year":"2020","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib72","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.ijrobp.2017.06.259","article-title":"Estimated benefit of dose reduction to highly ventilated lung regions for stage III non\u2013small cell lung cancer patients using normal tissue complication probability models","volume":"99","author":"Zhang","year":"2017","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105287_bib73","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ijrobp.2022.08.047","article-title":"Radiomics and dosiomics signature from whole lung predicts radiation pneumonitis: a model development study with prospective external validation and decision-curve analysis","volume":"115","author":"Zhang","year":"2023","journal-title":"Int. J. Radiat. Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T06:46:10Z","timestamp":1778481970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826001745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":73,"alternative-id":["S1040842826001745"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105287","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cumulative lung dose\u2013volume predictors of radiation pneumonitis in thoracic reirradiation: A systematic scoping review","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105287"}}